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Tuesday, February 5, 2013 389aflanking sequences from huntingtin. Also, we show that electrostatic repul-
sions due to these residues retard the rate of monomer loss and large, linear,
ordered clusters are formed. Our observations provide a unifying framework,
capturing all known features of the early stages of aggregation in polyglut-
amine containing systems.
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Core sequences of 4-7 residues that form amyloid fibrils have been identified
within natural amyloid proteins. However, the mechanism of amyloid aggrega-
tion remains unclear. We designed a new class of aliphatic peptides (with 3-6
residues) that self-assemble in water to amyloid b-type fibers via a-helical in-
termediates. We compared the self-assembly of our designed peptides with
core sequences in Amyloid-beta, Amylin and Calcitonin using amultimodal ap-
proach. A common featurewas the appearance of a-helical intermediates before
the final b-turn structures. Another amyloid-beta core sequence containing the
diphenylalanine motif was chosen to evaluate the role of aromatic residues in
self-assembly. The repeated occurrence of aromatic residues in core sequences
has led to widespread conclusions about
their key role in driving self-assembly. Sur-
prisingly, the diphenylalanine-containing
sequence did not form cross-b aggregates
or involve the a-helical intermediate step.
Our study puts forth a new, simplified
model system to study amyloidosis and in-
dicates that aromatic interactions are not as
important as previously postulated. The re-
sults provide valuable insight into the early
intermediates and factors driving self-assembly, which is necessary for devel-
oping small molecule therapeutic drugs that prevent amyloidosis.
1993-Pos Board B12
Discrete Molecular Dynamics Study of Oligomer Formation by
N-Terminally Truncated Amyloid B-Protein
Derya Meral, Brigita Urbanc.
Drexel University, Philadelphia, PA, USA.
Alzheimer’s disease (AD) is strongly linked to amyloid b-protein (Ab). Two
predominant alloforms, Ab140 and in particular Ab142, are known to
form toxic oligomers. The N-terminally truncated, pyroglutamated forms of
Ab140 and Ab142 are highly resistant to peptidase degradation and can
seed Ab aggregation. Discrete molecular dynamics (DMD) simulations previ-
ously captured in vitro derived distinct Ab140 and Ab142 oligomer size
distributions and predicted that the more toxic Ab142 oligomers had more
flexible and solvent exposed N-termini than Ab140 oligomers. Here, oligo-
mer formation by four N-terminally truncated Ab peptides: Ab340,
Ab342, Ab1140, and Ab1142 was examined by the DMD approach. In
our simulations, the four N-terminally truncated peptides showed increased
oligomerization propensity, consistent with their in vitro tendency to seed ag-
gregation. Conformations formed by Ab1140 had the lowest b-strand and the
highest turn content. The tertiary and quaternary structure of Ab34X oligo-
mers was distinctly different from that of Ab114X oligomers. Ab34X olig-
omers were characterized by more disordered and solvent exposed N-termini
than oligomers formed by the full-length peptides. In contrast, in comparison
to Ab14X, Ab114X oligomers had a more compact structure, facilitated
by Val12, resulting in less flexible and less solvent exposed N-termini, suggest-
ing reduced Ab114X-mediated toxicity. This unique behavior of the
N-termini in Ab peptides might provide a plausible explanation for the exper-
imentally observed increased toxicity of Ab34X peptides and their pyroglu-
tamated forms.
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Casein is the best characterized milk protein and constitutes over 70-80% of
total bovine milk protein. In milk, casein exists as large micelle-like particles
that comprise four unrelated proteins (as1-, as2-, b-, and k-casein) and calcium
phosphate. Although as1-, as2-, b-, and k-casein present important structuraldifferences, all of them adopt extremely open and flexible conformations,
enough to be defined intrinsically disordered proteins (IDPs). Caseins are
able to inhibiting protein aggregation and amyloid fibrils formation and this
chaperon-like activity could be largely due to their structural disorder. In the
present study we discuss the meaning of ‘‘disorder’’ in the case of three caseins
a, b and k that have similar unordered structure and different sequence. We cor-
relate the different type and disorder degree to the capability of preventing pro-
tein aggregation and amyloid formation. The physical-chemical parameters of
a, b and k caseins were compared to those of intrinsically unfolded and ideally
globular proteins. Moreover, caseins sequences were analyzed by several pub-
licly available disorder-oriented predictors two metaservers, MeDor and meta-
PRDOS, and by a neural network algorithm (PONDR). We observed that a,
b and k caseins have different degree and type of disorder, depending on the
parameters under analysis and criteria used by the different predictors. These
data were correlated to experimental results (ThT fluorescence, CD) on the ca-
seins effect on 1-40 b-amyloid peptide fibrillogenesis. Experiments showed
that k-casein forms ordered aggregates and that it is able to significantly in-
crease lag-time and reduce fibril amount in Ab amyloid formation. Our results
contribute to clear the role of intrinsically disordered proteins and their mech-
anism of action by functional order/disorder transitions, and offer insight in the
field of prevention and therapy in Alzheimer diseases, and, in general, of am-
yloid pathologies.
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The cellular polyamines spermine, spermidine, and their metabolic precursor
putrescine, have long been associated with cell-growth, tumor-related gene reg-
ulations, and Alzheimer’s disease. Here, we show by in-vitro spectroscopy and
AFM imaging, that these molecules promote aggregation of amyloid-beta (Ab)
peptides into fibrils and modulate the aggregation pathways. NMR measure-
ments showed that the three polyamines share a similar binding mode to mono-
meric Ab(1-40) peptide. Kinetic ThT studies showed that already very low
polyamine concentrations promote amyloid formation: addition of 10 mM sper-
mine (normal intracellular concentration is ~1 mM) significantly decreased the
lag and transition times of the aggregation process. Spermidine and putrescine
additions yielded similar but weaker effects. CD measurements demonstrated
that the three polyamines induce different aggregation pathways, involving dif-
ferent forms of induced secondary structure. This is supported by AFM images
showing that the three polyamines induce Ab(1-40) aggregates with different
morphologies. The results reinforce the notion that modulation of the Ab pep-
tide aggregation pathways towards minimally toxic ones by addition of suitable
ligands may be a possible therapeutic strategy for Alzheimer’s disease.
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Islet amyloid polypeptide (IAPP), also known as amylin, is a 37-residue intrin-
sically disordered hormone peptide that is secreted together with insulin by the
beta cells of the pancreas, and is involved in glucose regulation and gastric
emptying. IAPP is implicated in the pathogenesis of diabetes type II, due to
its deposition in the form of amyloid fibers in the beta cells of the pancreas,
where insulin is produced. IAPP contains a highly conserved, functional disul-
fide bond that confers a short ring-like structure (N_loop) to the N-terminus of
the peptide. Removal of this functional element alters both the mass per length
distributions of hIAPP fibers and the kinetics of fibril formation. The mecha-
nism by which the N_loop affects hIAPP aggregation is not yet understood,
